Liveware
Subscribe
Sign in
Home
Notes
Archive
About
Actions per minute
What StarCraft 2 taught me about B2B SaaS
May 23, 2025
•
Alex Telford
7
Some notes on the aesthetic of progress
Progress art as harmony between technology and nature
Mar 17, 2024
•
Alex Telford
27
8
5
But does surgery really work well without the FDA?
Or maybe the FDA is good actually
Feb 10, 2024
•
Alex Telford
13
13
2
The burden of prestige
Reflections on “The Trajectory of Discovery”, by Mark Khurana
Dec 19, 2023
•
Alex Telford
12
3
1
Depression as a local minima
Do antidepressants work via simulated annealing?
Dec 6, 2023
•
Alex Telford
7
3
1
Latent optima
In which I argue that information about optimality is encoded into datasets by selection processes
Nov 17, 2023
•
Alex Telford
2
Super Mario, scientist
What video game speedrunning can teach us about automating scientific discovery
Nov 7, 2023
•
Alex Telford
14
3
Schadenfreude in drug development
Optimism as a moral duty
Oct 26, 2023
•
Alex Telford
6
Should the UK embrace its role as an exporter of talent and ideas?
A proposal for a UK 'sovereign innovation fund'
Oct 19, 2023
•
Alex Telford
3
2
Concepts of health and disease as a barrier to progress
This essay was the runner-up in the Homeworld Ideas writing contest.
Oct 16, 2023
•
Alex Telford
8
1
Liveware
I write about the science and business of living things: the biotech industry, drug discovery, biology, medicine, consciousness, intelligence (artificial and natural), and natural philosophy. Mostly I write about the biotech industry.
Subscribe
Recommendations
Asimov Press
Asimov Press
The Roots of Progress
Jason Crawford
Asymmetric Learning - Pharmaceutical Innovation
Mike Rea, SAI/ IDEA Pharma
Liveware
Subscribe
About
Archive
Recommendations
Sitemap
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts